Patent Application
20230100793
The invention relates to a mask, in particular to a mask with a rapid-testing function.
Respiratory diseases, such as upper and lower respiratory tract infections and influenza, are symptoms of inflammation caused by viral, bacterial or other microbial infections of a patient. It may occur in people of all ages and be fatal when the disease is severe if the inflammation of influenza, COVID-19 (Coronavirus disease 2019) or pneumonia spreads.
Early detection and early treatment are the best way to prevent influenza, COVID-19 and pneumonia from worsening and being difficult to treat. To determine whether a suspected patient has symptoms of pneumonia, U.S. Pat. No. 10,073,097 discloses an in vitro method for diagnosing and treating pneumonia of the patient. The conventional pneumonia screening device needs to extract a biological sample of the patient. Therefore, the consumed screening time is long and the steps are more complicated. Usually, the in vitro method can only be carried out in a hospital, and it is difficult to have the function of early detection.
U.S. Patent No. US 2018/0256087A1 discloses another pneumonia screening device. The pneumonia screening device adopts portable design, which is convenient for real-time detection. However, the pneumonia screening device is a special appliance and needs to be purchased on purpose. As a result, the patient purchases and uses the device only when a disease condition has worsened significantly, so it is difficult to detect the symptoms of pneumonia at the first time and to receive early treatment.
The main purpose of the invention is to solve the problem that the conventional screening device is difficult to achieve early detection.
In order to achieve the above purpose, the invention provides a rapid-testing detection mask worn by a user and includes a covering portion, a lacing portion and a rapid-testing portion, wherein the covering portion is provided to cover the mouth and the nose of the user. The covering portion includes an inner layer and an outer layer, the inner layer is close to the user, and the outer layer is away from the user. The strap portion is connected to the covering portion and is worn on the user. The rapid-testing portion is arranged on the inner layer of the covering portion, and receives a gas to generate an indication signal according to the gas exhaled from the mouth or the nose of the user.
Accordingly, the invention provides a rapid-testing mask, which is worn by users infected with upper and lower respiratory tract infections. When wearing the rapid-testing mask, once the disease condition of the user worsens to have pneumonia or the user is infected with influenza or COVID-19, the gas is received through the rapid-testing portion to generate the indication signal accordingly, to achieve early detection. The user is noticed at the first time, and the user can undergo further detection and treatment to achieve the purpose of early treatment.
Referring to
The strap portion 20 is connected to the covering portion 10 and is worn on the user P. In an embodiment, the strap portion 20 comprises two cords 21 respectively looped and worn on ears E of the user P.
The rapid-testing portion 30 is arranged on the inner layer 101 of the covering portion 10. The rapid-testing portion 30 receives a gas A, and generates an indication signal according to the gas A. The gas A is exhaled from the mouth M or the nose N of the user P. The rapid-testing portion 30 comprises a base 31 and a material layer 32 that changes a color when absorbing a specific minimal substance (not shown). The material layer 32 is carried on the base 31 and absorbs the gas A. When the user P has one of pneumonia, influenza, or COVID-19, the gas A exhaled from the mouth M or the nose N of the user P contains the specific minimal substance. When the material layer 32 absorbs the gas A, that is, absorbs the specific minimal substance and changes the color, the material layer 32 that changed the color is used as the indication signal to warn that the user P may be infected with pneumonia, influenza, COVID-19, or the like. In other embodiments, the material layer 32 appears in the form of one line, two lines or no line to indicate whether the user has been infected or not.
In an embodiment, the covering portion 10 further comprises an adhesive layer 13. The adhesive layer 13 is arranged on the inner layer 101 to adhere the base 31 of the rapid-testing portion 30 to the inner layer 101. The rapid-testing portion 30 is fixed through the adhesive layer 13, so that the gas A exhaled from the mouth M or the nose N of the user P is received by the rapid-testing portion 30.
Referring to
As mentioned above, compared with conventional technique, the invention has following advantages:
1. The rapid-testing portion is built with the mask, which monitors whether the user has pneumonia, influenza and (COVID-19) at any time, so as to achieve the purpose of early detection and early treatment.
2. Through the rapid-testing portion (the material layer), appears in the form of changing the color, one line, two lines, or no line as the indication signal, to clearly know whether there is a risk of infection.
3. The rapid-testing portion is fixed through the adhesive layer or the pocket, so that the structure is simple and the cost is low.
4. In addition to provide the function of preventing disease infection in the mask, the rapid-testing portion is also used to detect whether the user is infected with pneumonia, influenza and COVID-19, to ensure the health of the user.
| Number | Date | Country | Kind |
|---|---|---|---|
| 110211390 | Sep 2021 | TW | national |
